B. Limits/Indications
1. Exceptions to cover routine foot care may be made for systemic conditions that result in sensory loss or circulatory compromise in the legs and feet (e.g., diabetes, arteriosclerosis obliterans, chronic thrombophlebitis, spinal cord injury with paraplegia or quadriplegia). The systemic disease must be of sufficient severity that the non-professional performance of the service would be hazardous.
2. Nail debridement of mycotic toenails (e.g. onychomycosis) is a covered benefit for the following indications only: a. Sensory loss or circulatory compromise of the lower extremities, or b. In the absence of systemic disease, for the following: i.
In an ambulatory patient there is documentation that includes clinical evidence of mycosis of the toenail, and there is marked limitation of ambulation due to pain or a secondary infection is present ii. In a nonambulatory patient there is documentation of clinical evidence of the mycosis and there is pain or a secondary infection is present.
3. Coverage is provided for the following: a. Surgical or chemical removal (partial or total) of the toenail when infected and distorted. Applicable diagnoses are onychocryptosis (ingrown toenail), onychomycosis (mycotic nail), onychogryphosis (deformed nail) and onychauxis (club nail). Local anesthesia, removal of medial and lateral (tibial and fibular) borders and pre and postoperative care are considered an integral part of the surgery and not separately billable.
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No. 91121-R7 Foot Care b. Subungual osteoectomy of a toe for removal of the toenail or matrix of the nail. c. Treatment of warts, including plantar warts. d. A simple (Silver procedure), modified (Keller, McBride or Mayo) or radical (Joplin) bunionectomy. Procedures with several components such as a bunionectomy with a sesamoidectomy are covered under one procedure code, in this case as a bunionectomy. e. Sesamoidectomy by itself when not performed in conjunction with other foot surgeries. f. Hammer Toe/Tenotomy when medically necessary. Surgery with tenotomy, whether one or multiple incisions, will be considered as one surgery. i. Follow-up fracture care related to the reduction of a fracture provided within 72 hours of the initial procedure are not separately billable. ii. Cast application, subsequent removal and reapplication, if required, and cast removal are covered as one medical service. In instances where the cast was applied in one geographical location and the removal done in another, coverage may be provided separately. iii. Windowing of a cast is considered a continuation of the original treatment and not separately billable. iv. Routine office visits related to the initial fracture care are a part of the initial procedure and not covered separately. c. Debridement with whirlpool treatment is covered as one procedure under debridement. d. Injections and aspirations of joints are covered procedures with the following limitations: i. Only one injection per joint is covered on the same day. ii. Therapeutic injections of the same joint are limited to a maximum of three injections in a six month period. e. Podiatric office surgery is covered. Ancillary services such as treatment room, recovery room, pre-operative services, services of nurses (e.g. scrub) are considered to be part of the normal office procedure. An assistant surgeon is covered for complex procedures only. f. Radiology services such as x-rays, including interpretation, are covered when disease or injury is present or suspected. Pre-and post-operative films are covered when invasive procedures are performed and services are provided in Plan. g. Bilateral non-invasive vascular studies, when unilateral surgery is being planned, are not a covered benefit.
5.
The following are excluded services: a. Routine foot care as noted in IA.
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No. 91121-R7 Foot Care b. Treatment of subluxation of the foot (partial dislocation or displacement of joint surfaces, tendons, ligaments, or muscles of the foot) performed for the sole purpose of correcting a subluxated structure in the foot as an isolated entity. This exclusion does not apply to medical or surgical treatment of subluxation of the ankle joint (talo-crural joint). In addition, treatment for an acute dislocation of the foot is covered. c. Acupuncture* d. Prolotherapy, joint sclerotherapy and ligamentous injection with sclerosing agents. e. Nerve blocks for the purpose of increasing blood supply to the foot and toes. f. Tenotomy for asymptomatic or passively correctable claw toes. g. Extracorporeal shock wave treatment for plantar fasciitis. h. Subtalar arthroereisis (subtalar implant) is considered experimental, investigational and unproven for all conditions including, but not limited to, flatfoot (pes planus), posterior tibial tendon dysfunction, and talipes valgus deformity.
*Note: Acupuncture may be covered with a rider for some commercial plans.
II. MEDICAL NECESSITY REVIEW

Required
Not Required Not Applicable
III. APPLICATION TO PRODUCTS
Coverage is subject to member's specific benefits. Group specific policy will supersede this policy when applicable. 
 HMO/EPO: This policy applies to insured HMO/EPO plans.  POS: This policy applies to insured POS plans.  PPO: This policy applies to insured PPO plans. Consult individual plan documents as state mandated benefits may apply. If there is a conflict between this policy and a plan document, the provisions of the plan document will govern.  ASO: For self-funded plans, consult individual plan documents. If there is a conflict between this policy and a self-funded plan document, the provisions of the plan document will govern.  INDIVIDUAL: For individual policies, consult the individual insurance policy. If there is a conflict between this medical policy and the individual insurance policy document, the provisions of the individual insurance policy will govern.  MEDICARE: Coverage is determined by the Centers for Medicare and Medicaid Services (CMS); if a coverage determination has not been adopted by CMS, this policy applies.  MEDICAID/HEALTHY MICHIGAN PLAN: For Medicaid/Healthy Michigan Plan members, this policy will apply. Coverage is based on medical necessity criteria being met and the appropriate code(s) from the coding section of this policy being included on the
IV. DESCRIPTION
The Foot Care policy outlines covered benefits for routine foot care and surgical and nonsurgical treatment of the foot. Lipid storage disorder, unspecified E77.0 -E77.9
Disorder of glycoprotein metabolism E85.0 -E85.9 Amyloidosis G04.1
Tropical spastic paraplegia G04.90 -G04.91
Encephalitis and encephalomyelitis, unspecified G10
Huntington's disease G11.0 -G11.2 Ataxia G11.4
Hereditary spastic paraplegia G11.9
Hereditary ataxia, unspecified G12.21
Amyotrophic lateral sclerosis G12.9
Spinal muscular atrophy, unspecified G13. 1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease G13.2 Systemic atrophy primarily affecting the central nervous system in myxedema G20
Parkinson's disease G21.4
Vascular parkinsonism G25. 3 Myoclonus G30.0 -G30.9
Alzheimer's disease G32.0
Subacute combined degeneration of spinal cord in diseases classified elsewhere G35
Multiple sclerosis G36.1
Acute and subacute hemorrhagic leukoencephalitis [Hurst] G36. 8 Other specified acute disseminated demyelination G37.1
Central demyelination of corpus callosum G37.2 Central pontine myelinolysis G37. 4 Subacute necrotizing myelitis of central nervous system G37. 8 Other specified demyelinating diseases of central nervous system G54. 4 Lumbosacral root disorders, not elsewhere classified G54. 8 Other nerve root and plexus disorders G55
Nerve root and plexus compressions in diseases classified elsewhere G57.00 -G57.52
Mononeuropathies of lower limb G57.90 -G57.92
Unspecified mononeuropathy of lower limb G60.0 -G60.9
Hereditary and idiopathic neuropathy G61.0 -G61.9
Inflammatory polyneuropathies G62.0 -G62.9
Other and unspecified polyneuropathy G63
Polyneuropathy in diseases classified elsewhere G64
Other disorders of peripheral nervous system G65.0 -G65. Myasthenic syndromes in other diseases classified elsewhere G80.0 -G80.9
Cerebral palsy G81.00 -G81.94
Hemiplegia and hemiparesis G82.20 -G82.54
Paraplegia and quadriplegia G83.10 -G83.14 Monoplegia of lower limb G83.30 -G83.34
Monoplegia unspecified G83. 4 Cauda equina syndrome G83.5
Locked-in state G83.81 -G83.9
Other specified paralytic syndromes G83.9
Paralytic syndrome, unspecified G95.0 Syringomyelia and syringobulbia G95.11 -G95.19
Vascular myelopathies G95.20 -G95.29
Other cord compression G95.9
Disease of spinal cord, unspecified G99.0
Autonomic neuropathy in diseases classified elsewhere I67.89
Other cerebrovascular disease I69.041 -I69.069
Sequelae of nontraumatic subarachnoid hemorrahage I69.141 -I69.169
Sequelae of nontraumatic intracerebral hemorrahage I69.241 -I69.269
Sequelae of other nontraumatic intracranial hemorrahage I69.341 -I69.369
Sequelae of cerebral infarction I69.841 -I69.869
Sequelae of other cerebrovascular diseases I69.941 -I69.969
Sequelae of unspecified cerebrovascular diseases I70.0 -I70.92 Atherosclerosis I72. 4 Aneurysm of artery of lower extremity I73.00 -I73.9
Other peripheral vascular diseases I74.3 -I74.9
Arterial embolism and thrombosis I77. 3 Arterial fibromuscular dysplasia I77.89
Other specified disorders of arteries and arterioles I77.9
Disorder of arteries and arterioles, unspecified I79.1
Aortitis in diseases classified elsewhere I79. 8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere I80.01 _ I80.03
Phlebitis and thrombophlebitis of superficial vessels lower extremity I80.11 -I80.13
Phlebitis and thrombophlebitis of femoral vein I80. 201 -I80.203 Phlebitis and thrombophlebitis of unspecified deep vessels of lower extremity I80.211 -I80.9
Phlebitis and thrombophlebitis other vessels I82. Enlarged and hypertrophic nails Q84. 6 Other congenital malformations of nails R20.0 -R20.9
Disturbances of skin sensation R89.9
Unspecified abnormal finding in specimens from other organs, systems and tissues S74.00xA -S74.92xS
Injury of nerves at hip and thigh level S84.00xA -S84.92xS
Injury of nerves at lower leg level S86.001A -S86.009S
Injury of muscle, fascia and tendon at lower leg level S86.091A -S86.109S
Other injury of muscle, fascia and tendon lower leg S86.191A -S86.209S
Other injury of other muscle(s) and tendon(s) S86.391A -S86.399S
Other injury of muscle(s) and tendon(s) of peroneal muscle group 86.801A -S86.809S
Unspecified injury of other muscle(s) and tendon(s) at lower leg
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S86.891A -S86.899S Other injury of other muscle(s) and tendon(s) lower leg S86.991A -S86.999S
Other injury of unspecified muscle and tendon lower leg S90.111A -S90.229S
Contusion of toes S90.411A -S90.476S
Other injuries to toes S90.811A -S90. 979S
Other injuries to foot S90.921A -S90.936S
Unspecified superficial injury of foot S91.101A -S91.259S
Open wound of toes S94.00xA -S94.92xS
Injury of nerves at ankle and foot level S96.001A -S96.009S
Injury of muscle and tendon at ankle and foot level S96.091A -S96.209S
Other injury of muscle and tendon ankle and foot level S97.101A -S97.129S
Crushing injury of toe(s) and foot S99.821A -S99.929S
Other specified injuries of foot T25.121A -T25.199S
Burn of first degree of foot T25.221A -T25.299S
Burn of second degree of foot and ankle T25.331A -T25.339S
Burn of third degree of foot T25.521A -T25.539S Corrosion of first degree of foot T25.621A -T25.699S
Corrosion of second degree foot T25.721A -T25.799S
Corrosion of third degree foot T33.521A -T33.539S Superficial frostbite of hand T33.821A -T33.839S Superficial frostbite of foot T34.521A -T34.539S
Frostbite with tissue necrosis of hand T34.811A -T34.839S
Frostbite with tissue necrosis of foot T49.0x1A -T49.0x4S Poisoning by local antifungal, anti-infective and antiinflammatory drugs T49.2x1A -T49.2x4S
Poisoning by local astringents and local detergents, accidental (unintentional), initial encounter T49.3x1A -T49.3x4S
Poisoning by emollients, demulcents and protectants Z79.01
Long term (current) use of anticoagulants Z79.899
Other long term (current) drug therapy Z86.2
Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism Z86.718
Personal history of other venous thrombosis and embolism Z86.72
Personal history of thrombophlebitis Z86.79
Personal history of other diseases of the circulatory system Z89.411-Z89.9
Acquired absence of lower limb OTHER FOOT PROCEDURES ICD-10 Codes that may support medical necessity: B07.0 Plantar wart B07. 8 Other viral warts M20.10 -M20.62
Acquired deformities of fingers and toes M65. 171 -M65.172 Infective (teno) synovitis, ankle and foot M65.80
Other synovitis and tenosynovitis, unspecified site M65. 871 -M65.879 Other synovitis and tenosynovitis, ankle and foot M65.9
Synovitis and tenosynovitis, unspecified M67.379
Transient synovitis, unspecified ankle and foot Open treatment of tarsal bone fracture (except talus and calcaneus), with or without internal or external fixation, each 28470
Closed treatment of metatarsal fracture; without manipulation, each 28475
Closed treatment of metatarsal fracture; with manipulation, each 28476
Percutaneous skeletal fixation of metatarsal fracture, with manipulation, each 28485
Open treatment of metatarsal fracture, with or without internal or external fixation, each 28490
Closed treatment of fracture great toe, phalanx or phalanges; without manipulation 28495
Closed treatment of fracture great toe, phalanx or phalanges; with manipulation 28496
Percutaneous skeletal fixation of fracture great toe, phalanx or phalanges, with manipulation 28505
Open treatment of fracture great toe, phalanx or phalanges, with or without internal or external fixation 28510
Closed treatment of fracture, phalanx or phalanges, other than great toe; without manipulation, each 28515
Closed treatment of fracture, phalanx or phalanges, other than great toe; with manipulation, each 28525
Open treatment of fracture, phalanx or phalanges, other than great toe, with or without internal or external fixation, each 28530
Closed treatment of sesamoid fracture 28531
Open treatment of sesamoid fracture, with or without internal fixation 28600
Closed treatment of tarsometatarsal joint dislocation; without anesthesia 28605
Closed treatment of tarsometatarsal joint dislocation; requiring anesthesia 28606
Percutaneous skeletal fixation of tarsometatarsal joint dislocation, with manipulation
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